These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 27688088

  • 41. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
    Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ.
    AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
    [Abstract] [Full Text] [Related]

  • 42. Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.
    Omatsu M, Kunimura T, Mikogami T, Shiokawa A, Nagai T, Masunaga A, Kitami A, Suzuki T, Kadokura M.
    Diagn Pathol; 2014 Dec 14; 9():215. PubMed ID: 25499804
    [Abstract] [Full Text] [Related]

  • 43. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
    Igai H, Matsuura N, Tarumi S, Chang SS, Misaki N, Go T, Ishikawa S, Yokomise H.
    Eur J Cardiothorac Surg; 2011 Jul 14; 40(1):143-5. PubMed ID: 20951602
    [Abstract] [Full Text] [Related]

  • 44. Diagnosis of thymic epithelial tumor subtypes by a quantitative proteomic approach.
    Zhao T, Wu J, Liu X, Zhang L, Chen G, Lu H.
    Analyst; 2018 May 29; 143(11):2491-2500. PubMed ID: 29645059
    [Abstract] [Full Text] [Related]

  • 45. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.
    Mod Pathol; 2002 Dec 29; 15(12):1326-32. PubMed ID: 12481014
    [Abstract] [Full Text] [Related]

  • 46. Pitfalls of FNA diagnosis of thymic tumors.
    Wang M, Kundu U, Gong Y.
    Cancer Cytopathol; 2020 Jan 29; 128(1):57-67. PubMed ID: 31742902
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. PAX1 expression in thymic epithelial neoplasms and morphologic mimics.
    Parrack PH, Hornick JL, Sholl LM.
    Hum Pathol; 2023 Dec 29; 142():7-14. PubMed ID: 37776957
    [Abstract] [Full Text] [Related]

  • 50. The distribution of epithelial membrane antigen in thymic epithelial neoplasms.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O.
    Cancer; 1992 Oct 15; 70(8):2077-81. PubMed ID: 1394038
    [Abstract] [Full Text] [Related]

  • 51. Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma.
    Taniguchi Y, Ishida M, Saito T, Ryota H, Utsumi T, Maru N, Matsui H, Hino H, Tsuta K, Murakawa T.
    Sci Rep; 2020 Jul 23; 10(1):12286. PubMed ID: 32704057
    [Abstract] [Full Text] [Related]

  • 52. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings.
    Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, Hamada S, Okumura M, Ohta M, Eimoto T, Miyagawa M, Müller NL, Ikezoe J, Nakamura H.
    AJR Am J Roentgenol; 2002 Oct 23; 179(4):881-6. PubMed ID: 12239030
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Hayashi I, Oriuchi N, Endo M, Kondo H, Nakajima T, Yamamoto N.
    Eur J Radiol; 2012 Sep 23; 81(9):2423-9. PubMed ID: 22055682
    [Abstract] [Full Text] [Related]

  • 55. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
    Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K, Okamoto T, Ikeda N, Tanaka F, Maniwa Y, Japanese Association for Research on the Thymus.
    Cancer; 2015 Apr 01; 121(7):1008-16. PubMed ID: 25565590
    [Abstract] [Full Text] [Related]

  • 56. Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma.
    Karube Y, Kobayashi S, Maeda S, Sado T, Ishihama H, Chida M.
    J Cardiothorac Surg; 2016 May 26; 11(1):85. PubMed ID: 27387303
    [Abstract] [Full Text] [Related]

  • 57. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
    Tateyama H, Eimoto T, Tada T, Hattori H, Murase T, Takino H.
    Am J Clin Pathol; 1999 Feb 26; 111(2):235-40. PubMed ID: 9930146
    [Abstract] [Full Text] [Related]

  • 58. Difference in the distribution of tumor-infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma.
    Yagi H, Nakaguro M, Ito M, Okumura Y, Takahashi S, Aoshima Y, Enomoto Y, Meguro S, Kawasaki H, Kosugi I, Shimoyama Y, Ogawa H, Tateyama H, Iwashita T.
    Pathol Int; 2021 Jul 26; 71(7):453-462. PubMed ID: 33819365
    [Abstract] [Full Text] [Related]

  • 59. PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis.
    Chen HF, Wu LX, Li XF, Zhu YC, Pan WW, Wang WX, Xu CW, Huang JH, Wu MH, Du KQ.
    Tumori; 2020 Aug 26; 106(4):306-311. PubMed ID: 32366210
    [Abstract] [Full Text] [Related]

  • 60. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE, Hiroshima K, Marchevsky AM.
    Ann Diagn Pathol; 2015 Aug 26; 19(4):216-20. PubMed ID: 25979154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.